Antigen structure and genetic basis of histo-blood groups A, B and O: Their changes associated with human cancer

Biochimica et Biophysica Acta - General Subjects

Volumn 1473, Issue 1, 1999, Pages 247-266

  Hakomori, Sen Itiroh ^a,b  

^a PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP A ANTIGEN; BLOOD GROUP ABH ANTIGEN; BLOOD GROUP B ANTIGEN; TRANSFERASE;

AMINO ACID SEQUENCE; ANTIGEN EXPRESSION; BLOOD GROUP ABO SYSTEM; DISEASE ASSOCIATION; HUMAN; MOLECULAR CLONING; PRIORITY JOURNAL; REVIEW; STRUCTURE ANALYSIS; TUMOR CELL;

ABO BLOOD-GROUP SYSTEM; ALLELES; AMINO ACID SEQUENCE; BASE SEQUENCE; CARBOHYDRATE SEQUENCE; CLONING, MOLECULAR; DNA, COMPLEMENTARY; EPITOPES; ERYTHROCYTE MEMBRANE; GLYCOSPHINGOLIPIDS; HEMATOPOIETIC STEM CELLS; HUMANS; INFANT, NEWBORN; LEWIS BLOOD-GROUP SYSTEM; MOLECULAR SEQUENCE DATA; N-ACETYLGALACTOSAMINYLTRANSFERASES; NEOPLASMS; PHENOTYPE;

EID: 0032760682     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(99)00183-X     Document Type: Review

References (109)

1. b-specificity. Br. Med. Bull. 25:1969;30-34.
2. b substances and their precursor I antigens, in: H. Isbell (Ed.), Carbohydrates in solution (Adv Chemistry Series 117), American Chemical Society, Washington, DC, 1973, pp. 334-361.
3. W.M. Watkins, Biochemistry and genetics of the ABO, Lewis and P blood group systems, in: H. Harris, K. Hirschhorn (Eds.), Advances in human genetics, Vol. 10, Plenum Press, New York, 1980, pp. 1-136.
4. A. Kobata, E.F. Grollman, B. Torain, V. Ginsburg, Genes, glycosyltransferases and blood types, in: D. Aminoff (Ed.), Blood and tissue antigens, Academic Press, New York, 1970 pp. 497-506.
5. Kobata A., Grollman E.F., Ginsburg V. An enzymic basis for blood type A in humans. Arch. Biochem. Biophys. 124:1968;609-612.
6. Race C., Ziderman D., Watkins W.M. An α-D-galactosyltransferase associated with the blood group B character. Biochem. J. 107:1968;733-735.
7. S. Hakomori, A. Kobata, Blood group antigens, in: M. Sela (Ed.), The antigens, Volume II, Academic Press, New York, 1974, pp. 79-140.
8. Schachter H., Michaels M.A., Crookston M.C., Tilley C.A., Crookston J.H. A quantitative difference in the activity of blood group A-specific N-acetylgalactosylaminyltransferase in serum from A1 and A2 human subjects. Biochem. Biophys. Res. Commun. 45:1971;1011-1018.
9. Schachter H., Michaels M.A., Tilley C.A., Crookston M.C., Crookston J.H. Qualitative differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and A2 genes. Proc. Natl. Acad. Sci. USA. 70:1973;220-224.
10. Masamune H., Siojima S. Chemistry and biology of lipids: VI. Group A lipid from stomach mucosa of pig, Tohoku. J. Exp. Med. 54:1951;319-326.
11. Masamune H., Hirata H. Chemistry and biology of lipids: Group lipoid from hog lung. Tohoku J. Exp. Med. 55:1952;233-241.
12. Tokura M. Chemistry and biology of lipids: VIII. Group A lipid from stomach mucosa of pig. Tohoku J. Exp. Med. 56:1952;299-307.
13. Yamakawa T., Iida T. Immunochemical study on the red blood cells: I. Globoside, as the agglutinogen of the ABO system on erythrocytes. Jpn. J. Exp. Med. 23:1953;327-331.
14. Yamakawa T., Nishimura S., Kamimura M. The chemistry of the lipids of posthemolytic residue or stroma of erythrocytes: XIII. Further studies on human red cell glycolipids. Jpn. J. Exp. Med. 35:1965;201-207.
15. Koscielak J., Zakrzewski K. Substance from erythrocyte of blood group A. Nature. 187:1960;516-519.
16. Koscielak J. Blood-group A specific glycolipids from human erythrocytes. Biochim. Biophys. Acta. 78:1963;313-328.
17. +. J. Biol. Chem. 236:1961;2827-2834.
18. Marchesi V.T., Andrews E.P. Glycoproteins Isolation from cell membranes with lithium diiodosalicylate. Science. 17:1971;1247-1248.
19. Yu J., Fischman D.A., Steck T.L. Selective solubilization of proteins and phospholipids from red blood cell membranes by nonionic detergents. J. Supramol. Struct. 3:1973;233-248.
20. Fukuda M.N., Fukuda M., Hakomori S. Cell surface modification by endo-β-galactosidase: Change of blood group activities and release of oligosaccharides from glycoproteins and glycosphingolipids of human erythrocytes. J. Biol. Chem. 254:1979;5458-5465.
21. Takasaki S., Yamashita K., Kobata A. The sugar chain structures of ABO blood group active glycoproteins obtained from human erythrocyte membrane. J. Biol. Chem. 253:1978;6086-6091.
22. 2 blood-group-specific glycoproteins. Eur. J. Biochem. 120:1981;243-249.
23. Hakomori S. Blood group ABH and Ii antigens of human erythrocytes: Chemistry, polymorphism and their developmental change. Semin. Hematol. 18:1981;39-62.
24. Clausen H., Hakomori S. ABH and related histo-blood group antigens: Immunochemical differences in carrier isotypes and their distribution. Vox Sang. 56:1989;1-20.
25. Hakomori S., Stellner K., Watanabe K. Four antigenic variants of blood group A glycolipid: Examples of highly complex, branched chain glycolipid of animal cell membrane. Biochem. Biophys. Res. Commun. 49:1972;1061-1068.
26. ®4)-2-deoxy-2-acetamido-glucosyl(1,3)] comprising more than one-third of the protein-bound carbohydrate of human erythrocyte stroma. J. Biol. Chem. 253:1978;8006-8009.
27. Fukuda M., Fukuda M.N., Papayannopoulou T., Hakomori S. Membrane differentiation in human erythroid cells: Unique profiles of cell surface glycoproteins expressed in erythroblasts in vitro from three ontogenic stages. Proc. Natl. Acad. Sci. USA. 77:1980;3474-3478.
28. Clausen H., Levery S.B., McKibbin J.M., Hakomori S. Blood group A determinants with mono- and difucosyl type 1 chain in human erythrocyte membranes. Biochemistry. 24:1985;3578-3586.
29. Marcus D.M., Cass L. Glycosphingolipids with Lewis blood group activity: Uptake by human erythrocytes. Science. 164:1969;553-555.
30. y) determinants in human blood cell membranes (ghosts): Evidence that type 2 chain can elongate repetitively but type 1 chain cannot. J. Biol. Chem. 260:1985;6410-6415.
31. a) epitope. Cancer Res. 51:1991;2199-2204.
32. 6) as human tumor-associated antigen. J. Biol. Chem. 266:1991;8439-8446.
33. 6). Eur. J. Biochem. 203:1992;577-586.
34. a glycosphingolipid, a novel extended type 1 chain antigen. Cancer Res. 52:1992;3739-3745.
35. Watanabe K., Hakomori S. Status of blood group carbohydrate chains in ontogenesis and in oncogenesis. J. Exp. Med. 144:1976;644-653.
36. Romans D.G., Tilley C.A., Dorrington K.J. Monogamous bivalency of IgG antibodies: I. Deficiency of branched ABHI-active oligosaccharide chains on red cells of infants causes the weak anti-globulin reactions in hemolytic disease of the newborn due to ABO incompatibility. J. Immunol. 124:1980;2807-2811.
37. Koscielak J., Miller-Podraza H., Krauze R., Piasek A. Isolation and characterization of poly(glycosyl)ceramides (megaloglycolipids) with A, H and I blood-group activities. Eur. J. Biochem. 71:1976;9-18.
38. Miller-Podraza H., Milh M.A., Bergstrom J., Karlsson K.-A. Recognition of glycoconjugates by Helicobacter pylori: An apparently high-affinity binding of human polyglycosylceramides, a second sialic acid-based specificity. Glycoconjug. J. 13:1996;453-460.
39. Niemann H., Watanabe K., Hakomori S., Childs R.A., Feizi T. Blood group i and I activities of 'lacto-N-norhexaosylceramide' and its analogues: The structural requirements for i-specificities. Biochem. Biophys. Res. Commun. 81:1978;1286-1293.
40. Watanabe K., Hakomori S., Childs R.A., Feizi T. Characterization of blood group I-active ganglioside: Structural requirements for I- and i-specificities. J. Biol. Chem. 254:1979;3221-3228.
41. Feizi T., Childs R.A., Watanabe K., Hakomori S. Three types of blood group I specificity among monoclonal anti-I autoantibodies revealed by analogues of a branched erythrocyte glycolipid. J. Exp. Med. 149:1979;975-980.
42. Marsh W.L. Anti-i: Cold antibody defining the Ii relationship in human red cells. Br. J. Haematol. 7:1961;200-209.
43. Giblett E.R., Crookston M.C. Aggutinability of red cells by anti-i in patients with thalassemia major and other haematological disorders. Nature. 201:1964;1138.
44. Fukuda M., Fukuda M.N., Hakomori S. Developmental change and genetic defect in the carbohydrate structure of Band 3 glycoprotein of human erythrocyte membrane. J. Biol. Chem. 254:1979;3700-3703.
45. 2 distinction. Proc. Natl. Acad. Sci. USA. 82:1985;1199-1203.
46. Clausen H., Levery S.B., Kannagi R., Hakomori S. Novel blood group H glycolipid antigens exclusively expressed in blood group A and AB erythrocytes (type 3 chain H): I. Isolation and chemical characterization. J. Biol. Chem. 261:1986;1380-1387.
47. c (abstract, in Japanese), Seikagaku. J. Jpn. Biochem. Soc. 58:1980;901.
48. 2 distinction. Biochem. Biophys. Res. Commun. 124:1984;523-529.
49. Kannagi R., Levery S.B., Ishigami F., Hakomori S., Shevinsky L.H., Knowles B.B., Solter D. New globoseries glycosphingolipids in human teratocarcinoma reactive with the monoclonal antibody directed to a developmentally regulated antigen, stage-specific embryonic antigen 3. J. Biol. Chem. 258:1983;8934-8942.
50. Bremer E.G., Levery S.B., Sonnino S., Ghidoni R., Canevari S., Kannagi R., Hakomori S. Characterization of a glycosphingolipid antigen defined by the monoclonal antibody MBr1 expressed in normal and neoplastic epithelial cells of human mammary gland. J. Biol. Chem. 259:1984;14773-14777.
51. Fenderson B.A., Andrews P.W., Nudelman E.D., Clausen H., Hakomori S. Glycolipid core structure switching from globo- to lacto- and ganglio-series during retinoic acid-induced differentiation of TERA-2-derived human embryonal carcinoma cells. Dev. Biol. 122:1987;21-34.
52. Stapleton A., Nudelman E.D., Clausen H., Hakomori S., Stamm W.E. Binding of uropathogenic Escherichia coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histo-blood group secretor status. J. Clin. Invest. 90:1992;965-972.
53. Oriol R., Le Pendu J., Mollicone R. Genetics of ABO, H, Lewis, X and related antigens. Vox Sang. 51:1986;161-171.
54. Whitehead J.S., Bella A.J., Kim Y.S. An N-acetylgalactosaminyltransferase from human blood group A plasma: I. Purification and agarose binding properties. J. Biol. Chem. 249:1974;3442-3447.
55. Nagai M., Dave V., Kaplan B.E., Yoshida A. Human blood group glycosyltransferases: I. Purification of N-acetylgalactosaminyltransferase. J. Biol. Chem. 253:1978;377-379.
56. ®3-N-acetylgalactosaminyltransferase from human lung tissue. J. Biol. Chem. 265:1990;1139-1145.
57. ®→3GalNAc transferase (histo-blood group A transferase) mRNA. J. Biol. Chem. 265:1990;1146-1151.
58. 2-terminal signal anchor. J. Biol. Chem. 262:1987;17735-17743.
59. Shaper N.L., Hollis G.F., Douglas J.G., Kirsch I.R., Shaper J.H. Characterization of the full length cDNA for murine β-1,4-galactosyltransferase: Novel features at the 5′-end predict two translational start sites at two in-frame AUGs. J. Biol. Chem. 263:1988;10420-10428.
60. Nakazawa K., Ando T., Kimura T., Narimatsu H. Cloning and sequencing of a full-length cDNA of mouse N-acetylglucosamine (β1-4)galactosyltransferase. J. Biochem. (Tokyo). 104:1988;165-168.
61. Paulson J.C., Colley K.J. Glycosyltransferases: Structure, localization and control of cell type-specific glycosylation. J. Biol. Chem. 264:1989;17615-17618.
62. Colley K.J. Golgi localization of glycosyltransferases: More questions than answers. Glycobiology. 7:1997;1-13.
63. Yamamoto F., Clausen H., White T., Marken J., Hakomori S. Molecular genetic basis of the histo-blood group ABO system. Nature. 345:1990;229-233.
64. Yamamoto F., Hakomori S. Sugar-nucleotide donor specificity of histo-blood group A and B transferases is based on amino acid substitutions. J. Biol. Chem. 265:1990;19257-19262.
65. Yamamoto F., McNeill P.D., Yamamoto M., Hakomori S., Bromilow I.M., Duguid J.K.M. Molecular genetic analysis of the ABO blood group system: 4. Another type of O allele. Vox Sang. 64:1993;175-178.
66. 2. Vox Sang. 67:1994;210-215.
67. 1 gene at the blood group ABO locus. Vox Sang. 70:1996;26-30.
68. el nucleotide insertion. Vox Sang. 71:1996;113-117.
69. R. Oriol, ABO, Hh, Lewis, and secretion: Serology, genetics and tissue distribution, in: J.P. Cartron , P. Rouger (Eds.), Blood cell biochemistry, Vol. 6., Molecular basis of human blood group antigens, Plenum Press, New York, 1995, pp. 37-73.
70. Olsson M.L., Santos S.E., Guerreiro J.F., Zago M.A., Chester M.A. Heterogeneity of the O alleles at the blood group ABO locus in Amerindians. Vox Sang. 74:1998;46-50.
71. 2 allele, one of the A subtypes is characterized by a single base deletion in the coding sequence, which results in an additional domain at the carboxyl terminal. Biochem. Biophys. Res. Commun. 187:1992;366-374.
72. R.R. Race, R. Sanger, Blood groups in man, Blackwell Scientific Publications, Oxford, 1975, p. 659.
73. (A) alleles. Vox Sang. 64:1993;171-174.
74. 3 alleles. Vox Sang. 64:1993;116-119.
75. EL allele-specific nucleotide insertion at the blood group ABO locus and its detection using a sequence-specific polymerase chain reaction. Biochem. Biophys. Res. Commun. 216:1995;642-647.
76. Hakomori S. Philip Levine Award Lecture: Blood group glycolipid antigens and their modifications as human cancer antigens. Am. J. Clin. Pathol. 82:1984;635-648.
77. Szulman A.E. The histological distribution of the blood group substances in man as disclosed by immunofluorescence: IV. The ABH antigens in embryos at the fifth week post fertilization. Human Pathol. 2:1971;575-585.
78. Yamamoto F., McNeill P.D., Hakomori S. Genomic organization of human histo-blood group ABO genes. Glycobiology. 5:1995;51-58.
79. Reed R., Maniatis T. A role for exon sequences and splice-site proximity in splice-site selection. Cell. 46:1986;681-690.
80. Bennett E.P., Steffensen R., Clausen H., Weghuis D.O., van Kessel A.G. Genomic cloning of the human histo-blood group ABO locus. Biochem. Biophys. Res. Commun. 206:1995;318-325.
81. Kominato Y., Tsuchiya T., Hata N., Takizawa H., Yamamoto F. Transcription of human ABO histo-blood group genes is dependent upon binding of transcription factor CBF/NF-Y to minisatellite sequence. J. Biol. Chem. 272:1997;25890-25898.
82. Hakomori S. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv. Cancer Res. 52:1989;257-331.
83. Oh-Uti K. Polysaccharides and a glycidamin in gastric cancer tissue. Tohoku J. Exp. Med. 51:1949;297-304.
84. Masamune H., Kawasaki H., Abe S., Oyama K., Yamaguchi Y. Molisch-positive mucopolysaccharides of gastric cancers as compared with the corresponding components of gastric mucosae. First report Fractionation procedure of gastric cancer and gastric mucosa. Tohoku J. Exp. Med. 68:1958;81-91.
85. Masamune H., Kawasaki H., Sinohara H., Abe S. Molisch-positive mucopolysaccharides of gastric cancers as compared with the corresponding components of gastric mucosae. Tohoku J. Exp. Med. 72:1960;328-336.
86. Davidsohn I., Stejskal R. Tissue antigens A, B and H in health and disease. Haematologia. 6:1972;177-184.
87. Dabelsteen E., Vedtofte P., Hakomori S., Young W.W.J. Accumulation of a blood group antigen precursor in oral premalignant lesions. Cancer Res. 43:1983;1451-1454.
88. Dabelsteen E., Pindborg J.J. Loss of epithelial blood group substance A in oral carcinomas. Acta Pathol. Microbiol. Scand. 81:1973;435-444.
89. Ørntoft T.F. Carbohydrate changes in bladder carcinomas. Acta Pathol. Microbiol. Immunol. Scand. 100:(Suppl. 27):1992;181-187.
90. Lee J.S., Ro J.Y., Sahin A.A., Hong W.K., Brown B.W., Mountain C.F., Hittelman W.N. Expression of blood-group antigen A: A favorable prognostic factor in non-small-cell lung cancer. N. Engl. J. Med. 324:1991;1084-1090.
91. Matsumoto H., Muramatsu H., Shimotakahara T., Yanagi M., Nishijima H., Mitani N., Baba K., Muramatsu T., Shimazu H. Correlation of expression of ABH blood group carbohydrate antigens with metastatic potential in human lung carcinomas. Cancer. 72:1993;75-81.
92. Ichikawa D., Handa K., Withers D.A., Hakomori S. Histo-blood group A/B versus H status of human carcinoma cells as correlated with haptotactic cell motility: Approach with A and B gene transfection. Cancer Res. 57:1997;3092-3096.
93. Ichikawa D., Handa K., Hakomori S. Histo-blood group A/B antigen deletion/ reduction vs. continuous expression in human tumor cells as correlated with their malignancy. Int. J. Cancer. 76:1998;284-289.
94. 1-glycolipid' to A or B-glycolipid and deficiency of these enzyme activities in adenocarcinoma. Biochem. Biophys. Res. Commun. 55:1973;439-445.
95. Ørntoft T.F., Meldgaard P., Pedersen B., Wolf H. The blood group ABO gene transcript is down-regulated in human bladder tumors and growth-stimulated urothelial cell lines. Cancer Res. 56:1996;1031-1036.
96. A.E. Mourant, A.C. Kopec, K. Domaniewska-Sobczak, Blood groups and diseases: A study of associations of diseases with blood groups and other polymorphisms, Oxford University Press, Oxford, 1978.
97. Clausen H., Hakomori S., Graem N., Dabelsteen E. Incompatible A antigen expressed in tumors of blood group O individuals: Immunochemical, immunohistologic and enzymatic characterization. J. Immunol. 136:1986;326-330.
98. Metoki R., Kakudo K., Tsuji Y., Teng N., Clausen H., Hakomori S. Deletion of histo-blood group A and B antigens and expression of incompatible A antigen in ovarian cancer. J. Natl. Cancer Inst. 81:1989;1151-1157.
99. David L., Leitao D., Sobrinho-Simoes M., Bennett E.P., White T., Mandel U., Dabelsteen E., Clausen H. Biosynthetic basis of incompatible histo-blood group A antigen expression: Anti-A transferase antibodies reactive with gastric cancer tissue of type O individuals. Cancer Res. 53:1993;5494-5500.
100. Masamune H., Hakomori S., Maehara T. Blood group lipid from human liver: I and II. Tohoku J. Exp. Med. 59:1954;225-246.
101. Franks D. Antigens as markers on cultured mammalian cells. Biol. Rev. Camb. Philos. Soc. 43:1968;17-50.
102. Pann C., Kuhns W.J. Differentiation of HeLa cells with respect to blood group H antigen. Nature (New Biology). 240:1972;22-24.
103. H. Nikaido, in: B. Davis, L. Warren (Eds.), Specificity of cell surfaces, Prentice-Hall, Englewood Cliffs, NJ, 1967, p. 95.
104. Andersson M., Carlin N., Leontein K., Lindquist U., Slettengren K. Structural studies of the O-antigenic polysaccharide of Escherichia coli O86, which possesses blood-group B activity. Carbohydr. Res. 185:1989;211-223.
105. Yang N., Boettcher B. Development of human ABO blood group A antigen on Escherichia coli Y1089 and Y1090. Immunol. Cell Biol. 70:1992;411-416.
106. Nowinski R., Berglund C., Lane J., Lostrom M., Bernstein I., Young W.W.J., Hakomori S., Hill L., Cooney M. Human monoclonal antibody against Forssman antigen. Science. 210:1980;537-539.
107. Springer G.F., Horton R.E., Forbes M. Origin of anti-human blood group B agglutinins in white leghorn chicks. J. Exp. Med. 110:1959;221-244.
108. Springer G.F., Horton R.E. Blood group isoantibody stimulation in man by feeding blood group-active bacteria. J. Clin. Invest. 48:1969;1280-1291.
109. Greenwell P. Blood group antigens: Molecules seeking a function? Glycoconjug. J. 14:1997;159-173.